Back

Prior cardiac ischemic injury exacerbates immune checkpoint inhibitor-induced cardiotoxicity

12 April 2024 (15:40 - 16:25)
Organised by: Logo
Congress Presentation Part of: Cardiotoxicity, cardiac fibrosis and metabolic cardiomyopathy Heart Failure CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2024 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Tamas Gergely

Gottsegen National Cardiovascular Center, Budapest (Hungary)

3 More presentations in this session

Presentation thumbnail
Innovative models for cardiotoxicity assessment in human pluripotent stem cell-derived cardiomyocytes that enable clinically relevant treatment regimen
Assistant Professor V. Schwach (Enschede, NL)
Abstract
Presentation thumbnail
The structural remodeling of the mitochondrial Ca2+ uniporter complex underlies its functional impairment during metabolic cardiomyopathy.
Mr M. Panel (Montpellier, FR)
Abstract
Presentation thumbnail
MicroRNA-mediated control of cardiac fibrosis: unraveling key players and mechanisms through functional genomics screenings
Doctor M. Mano (Coimbra, PT)
Abstract

Access the full session

Session thumbnail
Cardiotoxicity, cardiac fibrosis and metabolic cardiomyopathy

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2024

12 April 2024 15:40 CET
You may be interested in
thumbnail
Congress Presentation
Fetal recapitulation and cellular stress in the evolution and progression of heart failure
thumbnail
Congress Session
Heart Failure 2025 highlights
thumbnail
Congress Session
Unspoken aetiologies of heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources